Related references
Note: Only part of the references are listed.A Broken Antibiotic Market: Review of Strategies to Incentivize Drug Development
Sujata M. Bhavnani et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
Narrow-Spectrum Antibacterial Agents-Benefits and Challenges
Richard A. Alm et al.
ANTIBIOTICS-BASEL (2020)
Antibacterial Drug Development: A New Approach Is Needed for the Field to Survive and Thrive
M. Courtney Safir et al.
ANTIBIOTICS-BASEL (2020)
Generating Robust and Informative Nonclinical In Vitro and In Vivo Bacterial Infection Model Efficacy Data To Support Translation to Humans
Jurgen B. Bulitta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Synthesis of Antibiotics and Related Molecules
Mohammad Movassaghi et al.
JOURNAL OF ORGANIC CHEMISTRY (2018)
Narrow-spectrum antibacterial agents
Roberta J. Melander et al.
MEDCHEMCOMM (2018)
New Molecular Diagnostic Approaches to Bacterial Infections and Antibacterial Resistance
Ephraim L. Tsalik et al.
ANNUAL REVIEW OF MEDICINE, VOL 69 (2018)
Getting Drugs into Gram-Negative Bacteria: Rational Rules for Permeation through General Porins
Silvia Acosta-Gutierrez et al.
ACS INFECTIOUS DISEASES (2018)
Antibacterial Drug Discovery: Some Assembly Required
Ruben Tommasi et al.
ACS INFECTIOUS DISEASES (2018)
Predictive compound accumulation rules yield a broad - spectrum antibiotic
Michelle F. Richter et al.
NATURE (2017)
Bifurcation kinetics of drug uptake by Gram-negative bacteria
David A. Westfall et al.
PLOS ONE (2017)
Natural Products as Platforms To Overcome Antibiotic Resistance
Sean E. Rossiter et al.
CHEMICAL REVIEWS (2017)
Multidrug-Resistant Bacteria in the Community Trends and Lessons Learned
David van Duin et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2016)
Resistance Mechanisms and the Future of Bacterial Enoyl-Acyl Carrier Protein Reductase (FabI) Antibiotics
Jiangwei Yao et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
ESKAPEing the labyrinth of antibacterial discovery
Ruben Tommasi et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
On the exoneration of Dr. William H. Stewart: debunking an urban legend
Brad Spellberg et al.
INFECTIOUS DISEASES OF POVERTY (2013)
Challenges of Antibacterial Discovery
Lynn L. Silver
CLINICAL MICROBIOLOGY REVIEWS (2011)
Drugs for bad bugs: confronting the challenges of antibacterial discovery
David J. Payne et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
New (and not so new) antibacterial targets - from where and when will the novel drugs come?
SJ Projan
CURRENT OPINION IN PHARMACOLOGY (2002)
Share Paper
